Specific oncogene activation of the cell of origin in mucosal melanoma.
Saved in:
| Title: | Specific oncogene activation of the cell of origin in mucosal melanoma. |
|---|---|
| Authors: | Babu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Baron CS; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA., Sun K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Robitschek E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McConnell AM; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA., Wu C; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA., Dedeilia A; Massachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA., Sade-Feldman M; Massachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA., Modhurima R; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen KY; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA., Cox AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ludwig CG; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA., Kellis M; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.; MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hacohen N; Massachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA., Yang J; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.; MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA., Boland GM; Massachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA., Abraham BJ; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Zon LI; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA. leonard.zon@enders.tch.harvard.edu., Insco ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Megan_Insco@dfci.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2025 Jul 22; Vol. 16 (1), pp. 6750. Date of Electronic Publication: 2025 Jul 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
